With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

5 - Viracta Therapeutics: The cancer biotech has closed its doors ... or about 300 employees. Story Jan. 7 - Cassava Sciences: After reporting a phase 3 Alzheimer's fail in November, Cassava ...